Subscribe to Search results

Professor Frank Hill at the time believed hepatitis was a minor self limiting condition with no serious long-term consequences

Published on:

Dr Hill and Dr Stuart were concerned about the risks of hepatitis and were of the view that it would have been advantageous to reserve NHS Factor 8 for children.

Published on:

By 1975 Dr Colvin was aware that there was at least a possibility of chronic liver disease in haemophilia

Published on:

Dr Hill reported to the December 1979 meeting of the West Midlands Working Party that the Hepatitis Working Party had reported that Commercial Factor VIII carried the risk of hepatitis, and he was concerned that some children at the Childrens Hospital had become hepatitis carriers

Published on:

In 1979, Dr Kernoff held that while cryoprecipitate was cheap to produce it had serious clinical disadvantages and that the NHS's shortfall had to be addressed through buying commercial concentrate.

Published on:

In 1979, Dr Kernoff described NANBH was a serious disease with long-term consequences.

Published on:

In 1979 Dr Kernoff and Dr Colvin authorised guidelines for the screening and investigation of liver functioning and Hepatitis B tests, implementing closer monitoring of patients.

Published on:

In December 1979, the Haemophilia Working Party met and discussed the fact that up to 70% of patients with severe haemophilia had abnormal liver function tests, with a wide spectrum of histological abnormalities.

Published on:

In 1970, at the haemophilia centre at Leeds, based at St James's University Hospital Dr Layinka Swinburne was the director and in 1985, she was joined by Dr Bernard McVerry.

Published on:

By 1977 the haemophilia centre at Leeds, based at St James's University Hospital were using a substantial amount of commercial concentrates.

Published on:

The haemophilia centre at Leeds, based at St James's University Hospital showed no evidence of batch dedication or evidence of risk reduction.

Published on:

In 1978 at the haemophilia centre at Leeds, based at St James's University Hospital very little cryoprecipitate was in use.

Published on:

In 1979 at the haemophilia centre at Leeds, based at St James's University Hospital there was no cryoprecipitate was in use.

Published on:

The haemophilia centre at Leeds, based at St James's University Hospital showed that by 1977, was using a substantial volume of commercial concentrate.

Published on:

Dr Bevan described how, in 1978, there was a limited amount of risk management that took place during that period.

Published on:

Commenting on the reaction to AIDS and the risk of transmission, Dr Bevan held that during the period around 1983, that the general attitude of doctors was not to alarm the public as there was no conclusive proof.

Published on:

The haemophilia centre directors' annual meeting on 30 September 1980 included a discussion about the increasingly inadequate supplies of NHS factor VIII concentrate.

Published on:

In a meeting held by the haemophilia centre directors' annual meeting on 30 September 1980 Dr Craske stated that the use of small pooled concentrates would help reduce the risk of hepatitis in the haemophilic population

Published on:

A symposium was held, organised by Dr Forbes and the Royal College of Physicians and surgeons of Glasgow, which investigated liver disease in Haemophilia.

Published on:

In a meeting held by the haemophilia centre directors' annual meeting on 30 September 1980 discussed the risk of hepatitis in factor concentrates.

Published on: